Assessing a Polygenic Risk Score for Lung Cancer Susceptibility in Non-Hispanic White and Black Populations.


Journal

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
ISSN: 1538-7755
Titre abrégé: Cancer Epidemiol Biomarkers Prev
Pays: United States
ID NLM: 9200608

Informations de publication

Date de publication:
01 11 2023
Historique:
received: 22 02 2023
revised: 14 06 2023
accepted: 10 08 2023
medline: 2 11 2023
pubmed: 14 8 2023
entrez: 14 8 2023
Statut: ppublish

Résumé

Polygenic risk scores (PRS) have become an increasingly popular approach to evaluate cancer susceptibility, but have not adequately represented Black populations in model development. We used a previously published lung cancer PRS on the basis of 80 SNPs associated with lung cancer risk in the OncoArray cohort and validated in UK Biobank. The PRS was evaluated for association with lung cancer risk adjusting for age, sex, total pack-years, family history of lung cancer, history of chronic obstructive pulmonary disease, and the top five principal components for genetic ancestry. Among the 80 PRS SNPs included in the score, 14 were significantly associated with lung cancer risk (P < 0.05) in INHALE White participants, while there were no significant SNPs among INHALE Black participants. After adjusting for covariates, the PRS was significantly associated with risk in Whites (continuous score P = 0.007), but not in Blacks (continuous score P = 0.88). The PRS remained a statistically significant predictor of lung cancer risk in Whites ineligible for lung cancer screening under current U.S. Preventive Services Task Force guidelines (P = 0.02). Using a previously validated PRS, we did find some predictive ability for lung cancer in INHALE White participants beyond traditional risk factors. However, this effect was not observed in Black participants, indicating the need to develop and validate ancestry-specific lung cancer risk models. While a previously published lung cancer PRS was able to stratify White participants into different levels of risk, the model was not predictive in Blacks. Our findings highlight the need to develop and validate ancestry-specific lung cancer risk models.

Sections du résumé

BACKGROUND
Polygenic risk scores (PRS) have become an increasingly popular approach to evaluate cancer susceptibility, but have not adequately represented Black populations in model development.
METHODS
We used a previously published lung cancer PRS on the basis of 80 SNPs associated with lung cancer risk in the OncoArray cohort and validated in UK Biobank. The PRS was evaluated for association with lung cancer risk adjusting for age, sex, total pack-years, family history of lung cancer, history of chronic obstructive pulmonary disease, and the top five principal components for genetic ancestry.
RESULTS
Among the 80 PRS SNPs included in the score, 14 were significantly associated with lung cancer risk (P < 0.05) in INHALE White participants, while there were no significant SNPs among INHALE Black participants. After adjusting for covariates, the PRS was significantly associated with risk in Whites (continuous score P = 0.007), but not in Blacks (continuous score P = 0.88). The PRS remained a statistically significant predictor of lung cancer risk in Whites ineligible for lung cancer screening under current U.S. Preventive Services Task Force guidelines (P = 0.02).
CONCLUSIONS
Using a previously validated PRS, we did find some predictive ability for lung cancer in INHALE White participants beyond traditional risk factors. However, this effect was not observed in Black participants, indicating the need to develop and validate ancestry-specific lung cancer risk models.
IMPACT
While a previously published lung cancer PRS was able to stratify White participants into different levels of risk, the model was not predictive in Blacks. Our findings highlight the need to develop and validate ancestry-specific lung cancer risk models.

Identifiants

pubmed: 37578347
pii: 728438
doi: 10.1158/1055-9965.EPI-23-0174
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1558-1563

Subventions

Organisme : NCI NIH HHS
ID : R01 CA141769
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA022453
Pays : United States

Informations de copyright

©2023 American Association for Cancer Research.

Auteurs

Matthew R Trendowski (MR)

Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan.
Karmanos Cancer Institute, Detroit, Michigan.

Christine M Lusk (CM)

Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan.
Karmanos Cancer Institute, Detroit, Michigan.

Angela S Wenzlaff (AS)

Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan.
Karmanos Cancer Institute, Detroit, Michigan.

Christine Neslund-Dudas (C)

Department of Public Health Sciences, Henry Ford Health, Detroit, Michigan.
Henry Ford Cancer Institute, Henry Ford Health, Detroit, Michigan.

Shirish M Gadgeel (SM)

Henry Ford Cancer Institute, Henry Ford Health, Detroit, Michigan.

Ayman O Soubani (AO)

Karmanos Cancer Institute, Detroit, Michigan.
Division of Pulmonary, Critical Care and Sleep Medicine, Wayne State University School of Medicine, Detroit, Michigan.

Ann G Schwartz (AG)

Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan.
Karmanos Cancer Institute, Detroit, Michigan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH